Free shipping on all orders over $ 500

AZ31

Cat. No. M9128

All AbMole products are for research use only, cannot be used for human consumption.

AZ31 Structure
Synonym:

AZ-31

Size Price Availability
5mg USD 147  USD147 Custom Synthesis
10mg USD 250  USD250 Custom Synthesis
50mg USD 810  USD810 Custom Synthesis
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

AZ31 is a potent and highly selective ATM inhibitor with an IC50 of <0.0012 μM. AZ31 is the first selective orally active and bioavailable ATM kinase inhibitor.

In vivo, pharmacokinetic investigation of AZ31 as a single agent and in combination with irinotecan revealed that plasma concentrations of AZ31 were highest 1-hour after administration followed by a stepwise decrease at 3, 6 and 16 hour in the combination sensitive CRC098.

Protocol (for reference only)
Cell Experiment
Cell lines CRC (metastatic colorectal cancer) cell lines: HCT15, HCT116, RKO, CaCo2, LS123 and LOVO
Preparation method Six CRC cell lines were treated with AZ31 (dose 1.25, 2.5 or 5 μmol/L), SN38 (0.3125 -20 nM) or AZ31 + SN38 and proliferation was determined by an SRB assay.
Concentrations 1.25, 2.5 or 5 μmol/L
Incubation time 72 hours
Animal Experiment
Animal models CRC PDX models (Four-to-six week-old female athymic nude mice with implanted patient-derived colorectal adenocarcinoma tumor)
Formulation 10% v/v DMSO + 90% v/v Captisol at 30% w/v
Dosages 100 mg/kg-daily × 3
Administration oral gavage
Chemical Information
Molecular Weight 420.50
Formula C24H28N4O3
CAS Number 2088113-98-6
Solubility (25°C) DMSO: ≥ 40 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Kiesel BF, et al. J Pharm Biomed Anal. LC-MS/MS assay for the simultaneous quantitation of the ATM inhibitor AZ31 and the ATR inhibitor AZD6738 in mouse plasma.

[2] Degorce SL, et al. J Med Chem. Discovery of Novel 3-Quinoline Carboxamides as Potent, Selective, and Orally Bioavailable Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase.

Related ATM/ATR Products
KU-55933

KU-55933 is a cell-permeable ATP-competitive inhibitor of ATM (IC50 = 13 nM; Ki = 2.2 nM) with selectivity over other PIKK family kinases (IC50 = 2.5, 9.3, 16.6 μM for DNAPK, mTOR, PI 3-K, respectively; IC50 > 100 μM for PI 4-K and ATR).

KU-60019

KU-60019 is a potent ATM kinase inhibitor with IC50 of 6.3 nM.

VE-821

VE-821 is a highly selective and potent ATR inhibitor with IC50 of 26 nM.

ETP-46464

ETP-46464 is a potent inhibitor against mTOR, ATR, DNA-PK, PI 3-Kα and ATM with IC50 of 0.6, 14, 36, 170 and 545 nM, respectively.

CP-466722

Cp-466722 is a reversible ATM inhibitor with IC50 value of 4.1 μM, but has no effect on PI3K, PIKK family proteins.

  Catalog
Abmole Inhibitor Catalog




Keywords: AZ31, AZ-31 supplier, ATM/ATR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.